IRIS
SAVINO, Rocco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.400
AS - Asia 2.143
EU - Europa 832
SA - Sud America 495
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 6.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.287
SG - Singapore 1.015
CN - Cina 534
BR - Brasile 391
IT - Italia 373
VN - Vietnam 244
IN - India 187
SE - Svezia 118
DE - Germania 102
CA - Canada 86
GB - Regno Unito 84
AR - Argentina 47
HK - Hong Kong 44
FI - Finlandia 36
BD - Bangladesh 23
ID - Indonesia 18
ZA - Sudafrica 18
EC - Ecuador 17
MX - Messico 17
PL - Polonia 15
ES - Italia 14
IQ - Iraq 14
UA - Ucraina 13
TR - Turchia 12
JP - Giappone 11
RU - Federazione Russa 11
CZ - Repubblica Ceca 10
MA - Marocco 10
CO - Colombia 9
CL - Cile 8
AT - Austria 7
FR - Francia 7
KE - Kenya 7
NL - Olanda 7
PY - Paraguay 7
RO - Romania 7
EU - Europa 6
PE - Perù 6
UY - Uruguay 6
UZ - Uzbekistan 6
AU - Australia 5
EG - Egitto 5
TN - Tunisia 5
IE - Irlanda 4
IR - Iran 4
PK - Pakistan 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EE - Estonia 3
HN - Honduras 3
LV - Lettonia 3
SV - El Salvador 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BW - Botswana 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
SI - Slovenia 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
KI - Kiribati 1
LK - Sri Lanka 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.935
Salva come PNG Salva come JPEG
Città #
Dallas 527
San Jose 496
Chandler 357
Singapore 308
Ashburn 284
Santa Clara 162
Bengaluru 143
Hefei 142
Milan 135
Princeton 134
Lawrence 130
Ho Chi Minh City 82
Wilmington 79
Beijing 72
Catanzaro 70
Ottawa 67
Munich 63
Hanoi 56
Chicago 55
London 54
Boardman 51
Hong Kong 43
Des Moines 41
São Paulo 34
Turku 32
Shanghai 30
Troina 27
New York 25
Guangzhou 24
Los Angeles 20
Rome 19
The Dalles 18
Columbus 17
Council Bluffs 16
Seattle 16
Norwalk 15
Rio de Janeiro 15
Warsaw 15
Naples 14
Curitiba 13
Florence 12
San Francisco 12
Wuhan 12
Falls Church 11
Haiphong 11
Pune 11
Boston 10
Brooklyn 10
Tokyo 10
Da Nang 9
Olomouc 9
Redmond 9
Belo Horizonte 8
Bắc Ninh 8
Chennai 8
Cicciano 8
Hải Dương 8
Orem 8
Salvador 8
Shenzhen 8
Atlanta 7
Biên Hòa 7
Buenos Aires 7
Bắc Giang 7
Campinas 7
Johannesburg 7
Nairobi 7
Quito 7
Amsterdam 6
Ann Arbor 6
Brasília 6
Guayaquil 6
Hanover 6
Phoenix 6
Porto Alegre 6
Tashkent 6
Cape Town 5
Charlotte 5
Guarulhos 5
Jiaxing 5
Manchester 5
Montevideo 5
New Delhi 5
Parenti 5
Redwood City 5
Thái Bình 5
Washington 5
Baghdad 4
Cairo 4
Can Tho 4
Denver 4
Girona 4
Helsinki 4
Horia 4
Jakarta 4
Maceió 4
Mexico City 4
Mountain View 4
Sorocaba 4
Stockholm 4
Totale 4.302
Salva come PNG Salva come JPEG
Nome #
Untargeted metabolomics fingerprints in seminal plasma of patients with abnormal sperm morphology using high-performance liquid chromatography and mass spectrometry 194
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 96
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 96
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 88
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 84
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 82
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 80
Application of proteomics and peptidomics to COPD 79
An alternative approach for the identification of potential prostate cancer biomarkers 75
Mesopore-assisted Profiling of Human Synovial Fluid 74
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 73
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 73
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 72
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 71
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 71
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 71
Asthma and COPD proteomics: Current approaches and future directions 69
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 68
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 68
Associazione di antagonisti di IL-6 e farmaci anti-proliferativi (depositato il 10.3.2005 n. RM2005A000103) 67
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 66
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 66
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 66
MALDI MS-Based Investigations Targeting SARS-CoV-2 65
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 64
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 64
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 64
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 63
Adenovirus-mediated gene transfer of a human IL-6 antagonist 63
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 63
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 62
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 62
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 62
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 60
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 60
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 60
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 60
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 60
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 59
TLR4 triggered complex inflammation in human pancreatic islets 59
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 59
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 58
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 58
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 58
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 57
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 56
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 56
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 56
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 55
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 55
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 55
Biologics in severe asthma 55
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 53
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 53
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 53
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 53
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 52
test di Valutazione di efficacia dei chemioterapici effettuato su tre distinte e complementari popolazioni cellulari derivate dalla massa tumorale solida 51
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 51
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 51
A ROLE FOR U3 SMALL NUCLEAR RIBONUCLEOPROTEIN IN THE NUCLEOLUS 50
Involvement of the Arg179 in the active site of human IL-6 50
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 49
C3f is a potential tool for the staging of osteoarthritis 49
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 49
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 49
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 48
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 48
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 47
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 47
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 47
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 47
Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism 47
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 47
EXTRA-RIBOSOMAL SPACER SEQUENCES IN TRITURUS 46
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 46
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 46
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 46
The molecular design of human IL-6 receptor antagonists 45
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 45
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation 45
Human IL-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells 45
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 45
PRERIBOSOMAL RNA PROCESSING IN XENOPUS-OOCYTES DOES NOT INCLUDE CLEAVAGE WITHIN THE EXTERNAL TRANSCRIBED SPACER AS AN EARLY STEP 44
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 43
Human Herpesvirus Type 8 (HHV-8) Interleukin-6 homologue is functionally active on human myeloma cells 43
Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility 42
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 42
In Mesopore Protein Digestion: A New Forthcoming Strategy in Proteomics 42
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 42
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 42
MALDI MS-Based Investigations for SARS-CoV-2 Detection 42
Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a Helper-Dependent Adenoviral vector 41
Designing new agonists/antagonists of growth factor receptors- The rational design of a super-antagonist of the IL-6 receptor 40
Identification of residues critical for biological activity and receptor binding of human Interleukin-6 40
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 40
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 40
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus 40
Generation of IL-6 antagonists by substituting residues in helix A 39
Totale 5.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 8 0 6
2021/2022362 2 0 10 90 37 10 17 78 30 32 55 1
2022/20231.070 267 45 50 76 117 132 5 60 169 44 83 22
2023/2024420 63 59 54 22 26 100 4 24 5 7 11 45
2024/20251.527 216 140 77 87 122 167 5 29 183 125 143 233
2025/20263.364 172 365 717 604 332 146 349 205 362 112 0 0
Totale 7.036